Today: 29 April 2026
Visa stock slips toward $350 as proxy-season filings hit ahead of annual meeting
10 January 2026
1 min read

Visa stock slips toward $350 as proxy-season filings hit ahead of annual meeting

New York, Jan 10, 2026, 05:05 EST — Market closed

  • Visa ended Friday down 0.7% at $349.77, after touching a session low of $349.16.
  • A shareholder group urged investors to back a proposal seeking more disclosure on risks tied to deepfake content and payment activity.

Visa Inc shares closed down 0.7% on Friday at $349.77, leaving the stock about 7% below its 52-week high, after a shareholder filing pushed a fresh proposal into focus ahead of the company’s annual meeting.

The filing matters because it lands in the narrow window when big funds start sizing up proxy ballots and headline risk can whipsaw a steady, “defensive growth” name like Visa. It also comes after two straight down sessions for the stock, at a time when investors have been quick to fade anything that looks like distraction.

Visa fell even as the broader market rose on Friday, underperforming a rally that lifted the S&P 500 by 0.65%.

In its proxy materials, Visa has laid out the usual director elections and executive-pay vote, alongside shareholder proposals that can draw attention even when they rarely pass.

Beyond the proxy noise, traders are still treating the next results as the real test. In October, Visa forecast low double-digit net revenue growth for fiscal 2026; CFO Chris Suh said on the post-earnings call, “We saw broad-based strength, including improvements in retail services and goods, travel and fuel.” Reuters

Some investors have also been watching Visa’s push into tokenization — swapping card numbers for a digital token — which can cut fraud and smooth checkout, and has been pitched as more than just a security upgrade.

But cross-border growth, a key driver of fees for the payments networks, is what makes or breaks the quarter, and softer travel demand can show up fast in those numbers. Visa’s last reported quarter showed cross-border volume up 12%, and the company flagged continued strength in consumer spending, but investors remain alert to any cooling at the margin.

The next marker is Visa’s annual meeting on Jan. 27, followed by its next earnings report, which Nasdaq estimates for Jan. 29.

Stock Market Today

  • April FOMC US Index Levels Update: Dow Jones, Nasdaq, S&P 500
    April 29, 2026, 1:36 PM EDT. Stocks face volatility ahead of key earnings reports from tech giants Meta, Alphabet, Amazon, and Microsoft after market close. Investors seek signs that massive infrastructure spending and AI investments, fueled by trillions of dollars, are generating expected returns. This scrutiny recalls the 2025 AI/Tech crash triggered by unmet high expectations. Meanwhile, geopolitical tensions persist as the US-Iran standoff affects the Strait of Hormuz, pushing oil prices above $105 per barrel. Elevated crude prices raise concerns over inflation and market stability. The market waits on April FOMC signals and intraday performance metrics for the Dow Jones, Nasdaq, and S&P 500 to gauge risk appetite amid these economic and geopolitical pressures.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Apple Card switches banks: JPMorgan replaces Goldman in a two-year handoff
Previous Story

Apple Card switches banks: JPMorgan replaces Goldman in a two-year handoff

Intel stock surges 11% after Trump meeting — what investors watch before earnings
Next Story

Intel stock surges 11% after Trump meeting — what investors watch before earnings

Go toTop